7.24
-0.14(-1.90%)
Currency In USD
Address
8335 Sunset Boulevard
Los Angeles, CA 90069
United States of America
Phone
310-663-7831
Website
Sector
Healthcare
Industry
Biotechnology
Employees
8
First IPO Date
March 26, 2025
| Name | Title | Pay | Year Born |
| Dr. Thomas C. Chen M.D., Ph.D. | Founder, Chief Executive Officer, Chief Scientific Officer & Director | 212,000 | 1965 |
| Mr. Keithly A. Garnett | Chief Financial Officer & Director | 179,000 | 1975 |
| Mr. Patrick Walters CPA | Chief Operating Officer | 195,000 | 1956 |
| Mr. Amir Farrokh Heshmatpour | President, Executive Chairman & Secretary | 0 | 1967 |
Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.